Welcome to our dedicated page for Joint SEC filings (Ticker: JYNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Joint Corp. (NASDAQ: JYNT) files a range of reports and disclosures with the U.S. Securities and Exchange Commission that provide detailed insight into its operations as a national operator, manager and franchisor of chiropractic clinics. These SEC filings cover its Franchise Operations segment, refranchising activity, regional developer arrangements, credit facilities and stock repurchase programs, among other topics relevant to shareholders and analysts.
On this page, you can review The Joint Corp.’s key filings, including annual reports on Form 10-K and quarterly reports on Form 10-Q, which discuss its retail healthcare business model, classification as a lessor of nonfinancial intangible assets, and the performance of its franchised and company-owned or managed clinics. Current reports on Form 8-K provide timely disclosure of material events, such as asset purchase agreements to sell groups of clinics to franchisees, the acquisition or modification of regional developer rights, amendments to its revolving credit agreement, and board authorizations for additional stock repurchase capacity.
Filings also address accounting and reporting matters, including restatements of previously issued financial statements and related internal control considerations, as well as separation agreements with certain officers. Together, these documents outline how The Joint Corp. structures its franchise and management arrangements, manages its balance sheet and capital allocation, and responds to regulatory and governance requirements.
Stock Titan enhances access to these disclosures with real-time updates from the SEC’s EDGAR system and AI-powered summaries that explain the significance of complex filings. Users can quickly identify information related to refranchising transactions, development rights, credit facility amendments and other material events affecting JYNT, without reading every line of each report.
Joint (NASDAQ:JYNT) agreed to sell the assets of 31 company-owned clinics in Arizona and New Mexico to Joint Ventures, LLC for $11.07 million, with closing targeted on or before 30 Jun 2025 and customary conditions attached. In return, the company will obtain regional developer rights covering 46 existing franchised clinics and 30 future development sites across Northern California, Utah, Nevada, Washington and Oregon, enlarging its franchise pipeline.
In a separate transaction, the company divested five clinics in Kansas and Missouri to 93 Chiro, LLC. Management positions both deals as part of a strategic shift toward an asset-light, royalty-driven model that increases liquidity, cuts operating costs and accelerates unit growth.